PB

Paul A. Bunn

Clinical Advisor at Ascentage Pharma

Paul A. Bunn, Jr., MD, is the James Dudley Professor of Lung Cancer Research at the University of Colorado School of Medicine in Denver and a founding director of the University of Colorado Cancer Center. He has over 30 years of experience in oncology research, and his studies in lung cancer have been instrumental in the treatment of the disease—specifically in identifying biomarkers of prognosis and therapy selection. Throughout his career, Dr. Bunn has been President of ASCO, IASLC, and AACI, chairman of the FDA Oncology Drug Advisory Committee, and Executive Director of the IASLC. He is the author of numerous articles, book chapters, reviews and editorials as well as Principal Investigator on numerous national and local therapeutic trials and for the prestigious SPORE grant in lung cancer.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Ascentage Pharma

Ascentage Pharma is a global, clinical-stage biotechnology company engaged in developing novel therapies for cancers, CHB, and senesce diseases.


Industries

Headquarters

Suzhou, China

Employees

201-500

Links